Bloomberg
Thermo Fisher Rises as Instrument Demand Recovery Lifts Outlook
Thermo Fisher Scientific Inc. raised its revenue forecast after stronger-than-expected spending by biotech and pharma customers and a rebound in laboratory instrument demand helped pushed second-quarter sales past expectations. Shares…
View original source — Bloomberg ↗
Related stories
The Punch
BusinessJul 23, 2026 · 1 min
Dangote refinery completes $2.5bn equity placement
The Punch
MarketWatch
BusinessJul 23, 2026 · 1 min
These franchises have the lowest startup costs — and none are fast-food restaurants
MarketWatch
CNA
BusinessJul 23, 2026 · 1 min
US and allies say Russian hackers stole emails without social engineering
CNA
CNA
BusinessJul 23, 2026 · 1 min
Ubisoft maintains outlook, says some major titles delayed to 2028, 2029
CNA